Skip to main content

Table 4 Paraoxonase activity and biochemical parameters in metastatic and non-metastatic lung cancer patients

From: Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population

  Nonmetastatic LC patients (n=19) Metastatic LC patients (n=20) P value
Total cholesterol (mg/dl) 169.7 ± 57.6 160.7 ± 42.7 0.66
LDL cholesterol (mg/dl) 115.3 ± 45.8 116.6 ± 40.1 0.94
HDL cholesterol (mg/dl) 38.8 ± 28.5 31.1 ± 8.1 0.62
Triglyceride (mg/dl) 149.9 ± 55.7 133.2 ± 52.4 0.41
PON1 (U/mL) 245.6 ± 115.7 259.5 ± 94.9 0.70
ARE (U/L) 120 ± 47 153.9 ± 62.9 0.09
  1. Values are mean ± S.D. LC: Lung cancer, PON1: paraoxonase, ARE: arylesterase